Our data provide evidence of a novel regulatory pathway for melanogenesis in human skin.
Introduction
Melanocytes are neural crest-derived cells that migrate to the epidermis during embryogenesis and subsequently synthesize and distribute melanin to surrounding keratinocytes (reviewed in (1). The rate limiting enzyme in melanin biosynthesis is tyrosinase, and subsequent reactions involving tyrosinase and other melanogenic enzymes, tyrosinase related proteins (TRP) 1 and 2, result in melanin synthesis and deposition in specialized organelles called melanosomes (1).
The major known stimulator of melanin biosynthesis is ultraviolet (UV) irradiation (2). UV irradiation directly stimulates melanogenesis in pigment cells (3) and also induces the expression and synthesis of a variety of cytokines, primarily of keratinocyte origin, that act in a paracrine fashion to further induce melanogenesis (reviewed in (4) . In addition, several keratinocyte-derived cytokines known to inhibit human melanogenesis have been identified. These include interleukin (IL)-1α, a cytokine that is also produced by melanocytes (5), IL-6, tumor necrosis factor (TNF)-α (6) and transforming growth factor (TGF)-β1 (7, 8) . IL-1α, IL-2 6 and TNF-α were reported to inhibit melanogenesis by inhibiting tyrosinase activity (6) . They also decrease melanocyte proliferation, yet are not toxic to the cells (6) . However, the effect of these cytokines on tyrosinase expression, protein level and stability is not known.
More recently, it was reported that TGF-β1 also inhibits tyrosinase activity in B16 melanoma cells and in black non-agouti murine melanocytes (7, 8) . In B16 cells, TGF-β1 decreases tyrosinase expression and increases protein degradation (7) . Interestingly, in these cells TGF-β1 also decreases the protein level of TRP-1 without affecting its mRNA level (7) , suggesting that TGF-β1 inhibits melanogenesis, at least in part , by post translational modification of melanogenic enzymes.
Bone morphogenetic proteins are secreted signaling molecules that belong to the TGF-β superfamily (reviewed in (9) .
While originally identified as molecules that stimulate bone formation (10) , it is now well established that BMPs affect other tissues, inducing various effects like proliferation that oppose differentiation and apoptosis (reviewed in (11, 12) . To date, more than 20 different BMP proteins have been identified, all sharing structural homology and interaction with specific BMP receptors (11, 12) . BMP effects depend on many factors including tissue concentration (11, 13) , BMP type, presence of antagonists, embryonic stage of the target tissue and the type of receptors expressed by the target cells (9) .
BMPs bind two transmembrane receptors, BMP receptor (BMP-R)1 and BMP-R2 (11) . BMP-R1, when present as a monomer, binds BMP with low affinity.
However, when BMP-R1 and BMP-R2 are present as a heterodimer, their affinity for BMP is substantially increased (11) . Interestingly, to initiate signaling, BMP has to bind both receptors, inducing phosphorylation of an intracellular domain in BMP-R1 by BMP-R2 and activating intracellular signal transduction. Thus, both BMP-R1 and BMP-R2 are required to mediate BMP effects. Interestingly, there are several BMP-R1 receptors, BMP-R1A (Alk3), BMP-R1B (Alk6) and ActR-1 (Alk2) (14) and in neural precursor cells signaling through BMP-R1A induces their proliferation while BMP-R1B induces their differentiation (15) , suggesting that receptor expression determines BMP effect on cells.
Noggin is a secreted BMP antagonist that competes for binding to BMP receptors (reviewed in (16) . Our group has recently shown that mice overexpressing noggin in the hair follicle epithelium display darker coat color than wild type mice (17) , demonstrating that BMP signaling influence murine melanogenesis in vivo.
We now report that normal neonatal human melanocytes and keratinocytes express BMP-4. Melanocytes express in addition BMP-R1A, -1B and -2. BMP-4 stimulation of melanocytes leads to decreased tyrosinase mRNA, in part by decreasing message stability and in part by repressing tyrosinase promoter activity. BMP-4 also decreases tyrosinase protein and activity and decreases melanin level. Finally, UV irradiation transiently decreases the level of BMP-R1B in melanocytes, consistent with its role as the major environmental melanogenic stimulator.
Our study provides evidence of a novel signaling pathway that influences melanocyte function in human skin. 
Experimental Procedures Materials

Cell Culture
Primary melanocyte cultures were prepared from newborn foreskin as described (18) .
Primary cultures of melanocytes were sub-cultured and maintained in Medium 199 supplemented with 2% FBS, 10 ug/ml insulin, 10 -9 M triiodothyronine, 10 µg/ml transferrin, 10 ng/ml epidermal growth factor, 10 ug/ml myo-inostol 1.4 x 10 -6 M hydrocortisone, 10 ng/ml basic fibroblast growth factor 80 uM dibutyryl cAMP and bovine hypothalamic extract (100 ug/ml). MM4 human melanoma cells were obtained from Dr. U. Stierner (Gothenburg, Sweden) and maintained in DMEM (55%), L15 (27%), FBS (15%), nonessential amino acids (1%), glutamine (2 mM), and insulin (10 ug/ml) (19) .
Keratinocytes were established from neonatal foreskin or adult skin as described (20, 21) . For experimental use, first subcultures of the primary keratinocyte cultures were used. Cells were grown as previously described (21) in serum-free Medium 199 (GIBCO BRL, Gaithersburg, MD) containing 0.09 mM CaCl 2 with 10 µg/ml insulin (Sigma), 10 ng/ml epidermal growth factor (Bethesda Research Laboratories, Gaithersburg, MD), 10 -9 M triiodothyronine (Sigma), 10 µg/ml transferrin (Sigma), 1.4 x 10 -6 M hydrocortisone (Calbiochem-Behring Corp., La Jolla, CA), 2 µg/ml bovine serum albumin (Sigma), 10 µg/ml choline chloride (Sigma), and 10 µg/ml inositol (Sigma).
Melanin content 1 x 10
5 cells were spun at 2500 rpm for 15 min and the pellet was then dissolved in 0.5 ml of 1N NaOH. Melanin concentration was calculated by OD 475 and compared to a standard curve of synthetic melanin as previously described (22) .
Tyrosinase activity
Tyrosinase activity was measured up to 3 days after BMP-4 stimulation as described (23) . In brief, 5 x 10 5 cells were sonicated in 80mM PO 4 (pH 6.8) containing 1% Triton-X-100, and tyrosinase was extracted for 60 min at 4°C. 2-5 ug of cellular proteins were incubated with 31.25 uM L-tyrosine, 3.125 nM L-dihydroxyphenylalanine, and 5 uCi of L- [3,5- 3 H] tyrosine (40-60 Ci per mmol) for 30-60 min at 37°C.
The reaction was stopped by addition of 500 uL of 10% trichloroacetic acid and 250 ul of 0.2% bovine serum albumin. Trichloroacetic acid soluble material was reacted with Norit A and released 3 H 2 O was measured using a scintillation counter. The activity was expressed as counts per minute of 3 H 2 O released per microgram protein per hour minus the nonspecific incorporation of radioactivity, determined by using lysate boiled with β-mercaptoethanol for 30 min (background, generally less than 5%-10% of the sample).
DNA transfection
Plasmids containing the mouse 6.1 Kb tyrosinase promoter (pTYRCAT6) as well as deletion mutations of the promoter (60 bp, 280 bp and 3.8 Kb) (24, 25) and the empty vector (pBLCAT3) were transfected into MM4 cells together with a plasmid containing the renilla luciferase reporter gene (pRL-null Vector). The expression of renilla luciferase was used as an internal control to normalize the expression of firefly luciferase.
Twenty four hours before transfection, cells were plated at a density of 3x10 5 / 60 mm culture dish. Prior to transfection, medium was changed to DMEM and 4µg of pTYRCAT6 or pBLCAT3 together with 0.2 µg of pRL-null Vector were suspended in 12 µL Lipofectamine Reagent and 16µL of Plus Reagent and the suspension was added to the medium for three hours. Twenty-four hours after transfection, cells were supplemented with BMP-4 (25ng/ml) or vehicle alone. Two days after BMP-4 supplementation, total cellular proteins were harvested and equal amounts of proteins were analyzed using the Dual-Luciferase Reporter Assay System. Fluorescence intensity was determined using a luminometer (Turner Biosystems Model TD-20/20).
Northern blot analysis
Total RNA was isolated from cells with the Tri-Reagent kit (Gibco, Grand Island, NJ) following the protocol of the manufacturer. RNA concentrations were determined by absorbance at 260nm. The purity of the preparations was determined by the 260/280 O.D. ratio, which was consistently ≥1.8. Twenty ug/lane of denatured RNA samples were separated on 1% agarose gel containing 2.2M formaldehyde as previously described (26) . RNA was transferred onto nylon membranes (Hybond, Amersham Pharmacia Bioteck, UK) and was immobilized by shortwave UV irradiation (UV-Stratalinker 1800, Stratagene, La Jolla, CA). Blots were prehybridized for 2 hours at 45°C in a solution containing formamide, Denhart's solution, dextran sulfate and denatured salmon sperm DNA. Hybridization was carried out overnight at 45°C in the same solution containing 32 Plabeled tyrosinase cDNA. Autoradiography with XAR film (Eastman Kodak, Rochester, NY) and development after overnight exposure at -70 0 C was performed as described previously (27).
mRNA stability
Melanocytes were stimulated with BMP-4 (25ng/ml) or with diluent as above. At the time of BMP-4 treatment actinomycin D (5ug/ml) was added to cultures.
Total cellular RNA was harvested before and at different intervals after stimulation, processed for northern blotting and hybridized to tyrosinase cDNA. Tyrosinase mRNA half life was determined after densitometric analysis of band intensity.
Western blot analysis
Total cellular proteins were collected in RIPA buffer consisting of 0.25M Tris HCl (pH 7.5), 0.375M NaCl, 2.5% sodium deoxycholate, 1% Triton X-100, 25mM MgCl 2 , 1mM phenylmethyl sulfonyl fluoride, and 0.1 mg/ml aprotinin as described (26) . Protein concentrations were determined by the Bradford method and 50 to 100 µg protein/lane were processed for western blot analysis as described (26) . Antibody reactions were performed with mouse monoclonal anti tyrosinase antibody followed by HRP-tagged goat antimouse IgG (secondary antibody, BioRad Laboratories). The secondary antibodies were used at 1:2000 dilution. Antibody binding was detected by the ECL detection kit (Amersham, Piscatawya, NJ), followed by autoradiography (Kodak X-Omatic AR).
PCR amplification
Total melanocyte RNA was harvested as above. cDNA was generated by reverse transcription as described (27). Briefly, 2ug total RNA in a 20ul volume was reverse transcribed using oligo pd(N) 6 (Pharmacia Fine Chemicals, Piscataway, NJ) as a primer. Reverse transcription was carried out for 1 hour at 37 0 C. A 1 ul aliquot of this reverse transcription product (0.1ug of cDNA) was then amplified with 15 pmol of each forward and reverse primers complementary to the human published sequences (28 
Apoptosis analysis
DNA fragmentation as a measure of apoptosis was determined using the cell death detection ELISA PLUS kit and following the manufacturer's instructions (29) .
Briefly, melanocytes were stimulated with BMP-4 (25ng/ml) and cells were harvested 24 and 48 hours after stimulation. 1x10 4 cells were used as antigen source in a sandwich ELISA assay with a primary anti-histone antibody coated to the micro titer plate and a secondary anti-DNA antibody coupled to peroxidase. For positive control, we used the squamous carcinoma line SCC 12F (30), 24 and 48 hours after irradiation with 30mJ/cm 2 (metered at 285 ± 5 nm). (XMN 1000-21 ; Optical Radiation Corp., Azusa, CA) adjusted to 2 x 10 -4 W cm -2 was used to irradiate melanocytes in PBS through the petri dish plastic cover. This system delivers a spectral output virtually identical to that of terrestrial sunlight (31). Dosage was metered at 285 ± 5 nm with a research radiometer (model IL1700A; International Light, Inc., Newburyport, MA) fitted with a UVB probe (detector SSE 240, diffuser W, filter UVB). Dose was calculated to contain 20 mJ/cm 2 UVB, a dose that is physiologically relevant (3) and closely conforms to terrestrial sunlight (31).
UV irradiation
Sham-irradiated melanocytes were handled identically but were placed under aluminum foil cover during the irradiation. After irradiation, cells were provided their original medium and were harvested at different intervals after irradiation.
Densitometric Analysis
Autoradiograms of western and northern blots and PCR reactions were scanned into a computer (PC Dell™). Band intensity was determined after background subtraction using BIO-RAD Gel Doc 1000/2000 imaging densitometer.
Results
Normal human melanocytes express BMP receptor-and BMP-4 mRNAs
Total cellular RNA was isolated from melanocyte and keratinocyte cultures. Using sequence specific primers to BMP-R1A, -1B and -2 and the PCR technique, only samples of reverse transcribed melanocyte RNA showed bands at the expected molecular weights for BMP R-1A, -1B, -2 and BMP-4 and keratinocytes for BMP-4 when analyzed by ethidium bromide-stained agarose gel (Fig. 1) . The bands were sequenced and identified as BMP R-1A, -1B, -2 and BMP-4, respectively, by comparison to the working draft sequence of the human genome (BLAST at http://www.ncbi.nlm.nih.gov/genome /seq/).
BMP-4 decreases melanin synthesis
Preliminary experiments suggested that 25 ng/ml of BMP-4 decrease melanogenesis. Therefore, subconfluent melanocyte cultures were supplemented with BMP-4 (25ng/ml). Seventy two hours after supplementation proteins were harvested and total melanin/cell was determined. BMP-4 decreased melanin content by 47% ± 15% within 72 hours (p< 0.04, n = 5) ( Fig. 2A) .
Furthermore, tyrosinase activity, a reflection of melanin synthesis rate (1), was similarly inhibited by BMP-4, yielding a 34.0% ± 9.5% (mean ± SEM) decreased activity within 72 hours after stimulation as compared to diluent treated cells (p<0.05, n=3) (Fig 2B) .
BMP-4
downregulates tyrosinase mRNA and protein levels and decreases tyrosinase mRNA stability Because tyrosinase is considered the rate limiting enzyme in melanin biosynthesis (1), we investigated BMP-4 effect on tyrosinase mRNA and protein levels. Subconfluent melanocytes were stimulated with 25ng/ml BMP-4 and the expression of tyrosinase mRNA and protein was determined by northern and western blot analyses using tyrosinase cDNA ( Figure  3A ) and anti-tyrosinase antibodies ( Figure  3B ), respectively. The 2.4 kb band that represents tyrosinase mRNA was strongly expressed in melanocytes treated with diluent alone.
However, tyrosinase mRNA level was lower in cultures treated with BMP-4 [42% ± 16%, and 44% ± 17% (mean ± SEM) at 24 and 48 hours, respectively, p <0.02]. Similarly, the 66-68-kD band representing tyrosinase protein was reduced by BMP-4. In diluent treated cultures, tyrosinase protein increased with time, consistent with culture maturation. However, tyrosinase levels in BMP-4 treated cultures were lower: 42% ± 20% and 53% ± 29% (mean ± SEM) of diluent controls at 24 and 48 hours, respectively, (p <0.05), as determined by densitometry. These data suggest that the inhibitory effect of BMP-4 on melanin synthesis is mediated at least in part through inhibition of tyrosinase expression and synthesis.
To determine if BMP-4 transcriptionally regulates tyrosinase, BMP-4 effect on a 6.1 Kb mouse tyrosinase promoter as well as on three deletion mutations (3.8 Kb, 280 bp and 60 bp) was examined (24, 25) by transfecting MM4 melanoma cells that, like melanocytes, express BMP -R1A, -1B and -2 (data not shown). There was no consistent effect of BMP-4 on the activity of the 3.8 Kb, 280 bp and 60 bp promoters (data not shown). However, BMP-4 decreased the activity of the 6.1 Kb promoter by 27.4% ± 10.0% (mean ± SEM) (p<0.03, paired t-test, n=10) ( Figure  4A ). Although a small effect, it is significant, suggesting that BMP-4 effect on tyrosinase is in part transcriptionally mediated. To determine the BMP-4 effect on tyrosinase mRNA stability, melanocytes were stimulated with BMP-4 or diluent in the presence of actinomycin D. BMP-4 decreased tyrosinase mRNA half-life from >>6 hours to 4 hours (Fig.  4B) .
BMP-4 does not induce melanocyte apoptosis
To rule out the possibility that BMP-4 effect is the result of cell damage leading to apoptosis of more pigmented cells, melanocytes stimulated with BMP-4 (25ng/ml) were harvested 48 and 72 hours after stimulation and apoptosis was determined. There was no significant difference in the level of cytoplasmic DNA-histone between diluent-treated and BMP-4 treated cells (p=0.12), while SCC12F cells irradiated with a UV dose of 30mJ/cm 2 displayed a significantly higher level of the apoptotic products (p<0.02), comparable to the manu-facturer's positive control (Fig. 5) .
UV
irradiation decreases the expression of BMP-R1B Because UV irradiation is the major environmental stimulus for melanogenesis (tanning), and UV irradiation of epidermal melanocytes alone can lead to increased melanin synthesis (3), we investigated the effect of solar simulated irradiation on the expression of BMP-4 and its receptors. Melanocytes were exposed to 20 mJ/cm 2 UV irradiation metered at 285 ± 5 nm, and total cellular RNA from UV-and sham-irradiated cells was harvested 24, 48 and 72 hours after irradiation (Fig 6) . After correcting for loading as determined by the intensity of GAPDH bands, within 24 hrs, only the expression of BMP-R1B (Fig 6) was decreased 27% ± 5%, (mean ± STDEV) in UV-irradiated cells compared to shamirradiated cells, but there was no effect on BMP-R1A or BMP-R2, suggesting that UV irradiation enhances melanin production in melanocytes at least in part by decreasing the levels of BMP-R1B the receptor for the autocrine and paracrine melanogenic inhibitor BMP-4.____ Interestingly, within 48 hrs, BMP receptor expression in UV irradiated melanocytes was the same as in sham irradiated melanocytes, showing that the UV effect on BMP-R1B is rapid but transient.
Discussion
The present study demonstrates that normal human melanocytes express BMP receptors type 1A, 1B and 2 as well as BMP-4 and that surrounding keratinocytes express BMP-4, suggesting both autocrine and paracrine effects. Because the different primers that were used to amplify the cDNA to identify the different gene products most likely have different affinities to the cDNA, by RT-PCR it is impossible to compare their levels of expression. Nevertheless, the receptors are functional, as BMP-4 stimulation of melanocytes leads to decreased tyrosinase mRNA and protein levels and is accompanied by decreased melanogenesis. Our study is the first to document an effect of BMP in normal human melanocytes. It complements and expands a previous report from our laboratory demonstrating that noggin, the physiologic inhibitor of BMP that competes for binding to the BMP receptors, leads to darker coat color in mice when expressed as a transgene in the hair follicle epithelium (17).
The BMP-4 effect on melanogenesis appears specific and is not the result of non specific cellular toxicity, as BMP-4 did not induce morphologic changes or by guest on October 1, 2017 http://www.jbc.org/ Downloaded from melanocyte apoptosis; and was effective at doses widely used by other investigators (32) (33) (34) .
Using B16 mouse melanoma cells and melan-a, black non-agouti murine melanocytes, Martinez-Esparza et al reported (7, 8) that TGF-β1, a molecule that belongs to the superfamily of molecules that includes BMPs (9), decreased tyrosinase and TRP-1 levels (7) and activity (7, 8) . The decreased levels of the melanogenic proteins were interpreted to be the result of decreased gene expression as well as increased protein degradation (7) . In the current study we have not examined tyrosinase protein stability and it is possible that, like TGF-β1, BMP-4 also modulates protein degradation in melanocytes. Regardless, our studies demonstrate that BMP-4 inhibits melanogenesis in part via its effect on tyrosinase mRNA stability and in part through tyrosinase promoter repression.
Our results may be viewed as contradictory to those of Bilodeau et al., who reported that BMP-2 stimulation of quail neural crest cells leads to increased melanogenesis by stimulating tyrosinase gene expression (35) . Although it is possible that the reason for the discrepancy is the use of cells from divergent species (quail vs. human), or that BMP-2 exerts different effects than BMP-4, we believe that the divergent results are more likely the consequence of BMP signaling through distinct type 1 receptors expressed by the cells. Bilodeau did not determine BMP receptors expressed by quail neural crest cells (35) , but it is well documented that during murine embryonic development, BMPs may exert opposite effects on neural crest cells depending on their maturational state. BMPs cause apoptosis of early CNS precursor cells (36, 37) but differentiation of the same cells in mid and late gestation (38) (39) (40) . Interestingly, Panchision et al. (15) recently suggested that BMP effects depend on the type of receptors that are expressed by the cells at the time of stimulation. Specifically, they showed that murine neural precursor cells do not express BMP-R1B until embryonic day 9, and that only prior to this time, when BMP-R1A is expressed alone, BMP stimulates their proliferation. Conversely, when both receptors are present, in later stages of development, BMP signals through BMP-R1B, causing mitotic arrest and differentiation. Thus, opposite effects of BMPs, even on cells of identical lineage derived from the same species, are well documented, and might readily explain the apparent discrepancy between our study and that of Bilodeau et al.
Melanin synthesis is influenced by a variety of cytokines, primarily of keratinocyte origin (41) . These include endothelin-1 (42-44), α-melanocyte stimulating hormone (45, 46) , a proopiomelanocortin-derived peptide that is also produced by melanocytes (46) , and basic fibroblast growth factor, a nonsecreted, keratinocyte anchored cytokine (47) . Not surprisingly, synthesis of the above modulators of melanogenesis is induced by UV irradiation (reviewed in (4) . In addition to melanogenic stimulators, keratinocytes synthesize and secrete cytokines that inhibit melanogenesis, including IL-1α, a cytokine that is also produced by melanocytes (5), IL-6, TNF-α (6) and TGF-β1 (7). Consistent with the paradigm that UV irradiation increases the level and efficacy of melanogenic stimulators and reduces the level of melanogenic inhibitors, our data show that physiologic levels of UV irradiation substantially reduce the level of BMP-R1B in melanocytes. In this regard, it is tempting to speculate that, as in murine neural precursor cells, in melanocytes BMP-R1B mediates the differentiated function of the cells including melanogenesis, while BMP-R1A contributes to their proliferation. Hence, physiologic UV irradiation would be expected to down-regulate only the receptor that inhibits melanogenesis and not the receptor that affects proliferation, consistent with reports showing that UV irradiation leads to delayed melanocyte proliferation (48, 49) .
UV irradiation is known to activate multiple transcription factors including p53 (50), NF-κB (51), AP-1 (52), E2F (53) and Oct-1 (54). In addition, UV "photofootprinting", a technique using UV irradiation as a tool to identify protein-DNA interactions (55), has identified the sequence CCAAT as binding transcription factors induced by UV-irradiation (56) . Unfortunately, the promoter area of human BMP-R1B has not been characterized to date and a detailed examination of BMP-R1B promoter will be of interest once the sequence has been elucidated.
In conclusion, we have identified a novel autocrine inhibitor of melanogenesis, BMP-4, and have shown that melanocytes express functional BMP receptors.
We show that the BMP-4 effect is mediated through both transcriptional and post-transcriptional events leading to tyrosinase promoter partial repression as well as decreased tyrosinase mRNA stability and levels. Further, we show that UV irradiation, a potent melanogenic stimulator, decreases the expression of BMP-R1B. Our study provides evidence of a novel signaling pathway that influences melanocyte function in human skin, and suggests a new perspective from which to investigate pigmentary disorders. 1 Kb mouse tyrosinase promoter and then were stimulated with BMP-4 (25mg/ml) or diluent and promoter activity was determined as per Materials and Methods. Results are expressed as CAT activity in (BMP-4 cultures/diluent cultures) X 100. BMP-4 decreases promoter activity by 27.4% ± 10.0% (mean ± SEM) in a total of 10 independent experiments (p<0.03, paired t-test). (B) mRNA degradation rate in melanocytes stimulated with BMP-4 is higher than in melanocytes stimulated with diluent.
Figure 5 BMP-4 does not induce melanocyte apoptosis
To explore the possibility that BMP-4 is toxic to melanocytes, cells were maintained for 48 and 72 hours in the presence of BMP-4. Melanocyte apoptosis was determined using the cell death detection ELISA assay, which measures cytoplasmic histone-associated mono-and oligonucleosomes generated as a result of apoptosis. Melanocytes treated with BMP-4 did not display apoptosis above the low background level, while UV irradiated SCC12F cells showed >100 fold increase in reaction product 72 hours after irradiation, as expected. The positive control (DNA-histone complex) included in the kit shows the expected high signal, confirming that the different compounds provided in the kit are functional. 
